Association of the lung immune prognostic index with the survival of patients with idiopathic interstitial pneumonias.

Background and Objective: The lung immune prognostic index (LIPI), a simple index calculated from the blood lactate dehydrogenase level and derived neutrophil‐to‐lymphocyte ratio, is thought to be associated with host immune status. However, the utility of LIPI in patients with idiopathic interstitial pneumonias (IIPs) is unknown. Methods: In this multicentre, retrospective, observational study, an association between LIPI and the survival of patients with IIPs was evaluated. Results: Exploratory and validation cohorts consisting of 460 and 414 patients with IIPs, respectively, were included (159 and 159 patients had idiopathic pulmonary fibrosis [IPF], and 301 and 255 had non‐IPF, respectively). In the exploratory cohort, patients with IPF and a low LIPI had significantly better survival than those with a high LIPI (median of 5.6 years vs. 3.9 years, p = 0.016). The predictive ability of LIPI for the survival of patients with IPF was validated in the validation cohort (median of 8.5 years vs. 4.4 years, p = 0.003). In a multivariate Cox proportional hazard analysis, LIPI was selected as an independent predictive factor for the survival of IPF patients. There was no significant association between LIPI and survival of non‐IPF patients in the exploratory and validation cohorts. Conclusion: The LIPI was a predictive factor for the survival of patients with IPF and could aid the management of IPF. [ABSTRACT FROM AUTHOR]